Xu Lan, Cao Yi
First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310000, China.
Department of Dermatology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Zhejiang Provincial Hospital of Chinese Medicine, Hangzhou, Zhejiang, 310006, China.
Arch Dermatol Res. 2025 Jan 16;317(1):268. doi: 10.1007/s00403-025-03805-y.
The relationship between psoriasis and osteopenia remains undetermined. Patients with psoriasis tend to have a higher Body Mass Index (BMI) compared to those without the condition. While it appears plausible that BMI could mediate this association, further study is required to confirm this hypothesis. The objective of this study is to ascertain whether BMI plays a role in influencing the impact of psoriasis on osteopenia. This study encompassed 2,624 participants from the National Health and Nutrition Examination Survey (NHANES) conducted between 2003 and 2006. The condition of psoriasis was self-reported, while osteopenia was assessed based on bone mineral density (BMD) range and self-reported osteoporosis. BMI was derived from NHANES body measurement data. Weighted logistic regression analyses and mediation analysis were utilized to elucidate the relationship. Subgroup differences were further explored in the absence of a clear relationship. A positive correlation was observed between psoriasis and osteopenia. Furthermore, BMI was positively related to psoriasis and negatively related to osteopenia. Additionally, BMI served as a mediator in the relationship between psoriasis and osteopenia, accounting for 20.8% of the variance. Specifically, the mediating influence of BMI exhibited variations based on diabetes status and gender. In conclusion, Controlling BMI could potentially mitigate the impact of psoriasis on osteopenia. Therefore, we advocate for a rigorous focus on bone health in individuals with psoriasis, particularly among males and non-diabetic populations.
银屑病与骨质减少之间的关系仍未确定。与未患该病的患者相比,银屑病患者往往具有更高的体重指数(BMI)。虽然BMI可能介导这种关联似乎是合理的,但需要进一步研究来证实这一假设。本研究的目的是确定BMI是否在影响银屑病对骨质减少的作用中发挥作用。本研究纳入了2003年至2006年期间进行的美国国家健康与营养检查调查(NHANES)中的2624名参与者。银屑病状况通过自我报告,而骨质减少则根据骨矿物质密度(BMD)范围和自我报告的骨质疏松症进行评估。BMI来自NHANES的身体测量数据。采用加权逻辑回归分析和中介分析来阐明这种关系。在没有明确关系的情况下进一步探讨亚组差异。观察到银屑病与骨质减少之间存在正相关。此外,BMI与银屑病呈正相关,与骨质减少呈负相关。此外,BMI在银屑病与骨质减少之间的关系中起中介作用,占变异的20.8%。具体而言,BMI的中介影响因糖尿病状态和性别而异。总之,控制BMI可能会减轻银屑病对骨质减少的影响。因此,我们主张对银屑病患者,特别是男性和非糖尿病人群的骨骼健康给予严格关注。